Goodwin represented Akero Therapeutics, Inc., which announced today the completion of a $65 million Series A financing. The financing will be used to advance Akero’s lead…
Standard 1 Year Membership Required
You must be a Standard 1 Year member to access this content.
Already a member? Log in here
